Corporate-Responsibility600x400Information for Healthcare Professionals

Purdue advocates for responsible use of opioids. We recommend healthcare providers review resources provided by government agencies including:

Purdue also encourages all healthcare providers to participate in continuing medical education (CME/CE) programs offered by the US Food and Drug Administration’s Risk Evaluation and Mitigation Strategy (REMS). This initiative is intended to manage known or potential serious risks associated with a drug product to ensure that the benefits of a drug outweigh its risks. For more information, please visit
http://er-la-opioidrems.com or call 800-503-0784.

The prescription and illicit opioid abuse crisis is a multifaceted public health challenge, and as a manufacturer of prescription opioids, we have a responsibility to join the fight. At Purdue we are committed to lead our industry in helping address our nation's prescription and illicit opioid abuse crisis.

There is more to come – as we continue to work with partners and experts to deliver solutions. Below you will find additional information about our efforts.

Read our open letter about the opioid crisis.